Error in Figure
In the original publication [1], there was a mistake in Figure 4 as published. The representative picture of the immunohistochemistry staining for aSMA of the group entitled BLM (w1-6) + nintedanib (w4-6) was erroneously selected from a different group of mice. The corrected Figure 4 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Figure 4.
Treatment with 17-DMAG prevents further progression and may induce regression of proliferation of myofibroblasts induced by bleomycin. (A) Representative images of α-smooth muscle actin (aSMA)-stained skin sections are shown. aSMA-positive cells are stained brown, nuclei are counterstained blue by hematoxylin. Original magnification ×400. (B) Treatment with 17-DMAG prevents further progression and induces regression of the proliferation of myofibroblasts induced by bleomycin. The extent of the protective effects of 17-DMAG is comparable to the effect of the treatment with nintedanib. Columns represent the mean, and whiskers represent the standard error of the mean. w, week; NaCl, sodium chloride; BLM, bleomycin; 17-DMAG, 17-dimethylaminoethylamino-17-demethoxygeldanamycin (inhibitor of Heat shock protein 90); ns, not significant (p ≥ 0.05); n = 8 mice in each group.
Reference
- Štorkánová, H.; Štorkánová, L.; Navrátilová, A.; Bečvář, V.; Hulejová, H.; Oreská, S.; Heřmánková, B.; Špiritović, M.; Bečvář, R.; Pavelka, K.; et al. Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin. Biomedicines 2021, 9, 650. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).